Background: Histamine plays a central role in the pathogenesis of allergic
and inflammatory diseases by modulating vascular and airway responses. Incr
easing evidence suggests that histamine also regulates the function of infl
ammatory and immune cells. Macrophages are primarily involved in inflammato
ry diseases of the lung. We explored the ability of low concentrations of h
istamine to induce the release of proinflammatory mediators from human lung
macrophages. Methods: Macrophages purified (>95%) from lung parenchyma by
Percoll density gradients and adherence to polystyrene dishes were incubate
d (37 degreesC, 2-24 h) with histamine (10(-9)-10(-6) M). At the end of inc
ubation, the release of beta -glucuronidase and IL-6 was determined. Result
s: Histamine induced a concentration-dependent release of beta -glucuronida
se and IL-6 with a maximum release after 2 and 6 h of incubation, respectiv
ely. Exocytosis induced by histamine was noncytotoxic and was Ca2+- and tem
perature-dependent. The effect of histamine was inhibited by the H-1 recept
or antagonist fexofenadine but not by the H-2 antagonist ranitidine. Conclu
sions: These data indicate that histamine is an effective stimulus for exoc
ytosis and cytokine production from human lung macrophages. These effects a
re inhibited by pharmacological concentrations of fexofenadine. Our results
suggest that histamine may contribute to the long-term evolution of lung i
nflammation and tissue remodelling in allergic diseases by modulating the p
roduction of proinflammatory and immunoregulatory mediators by macrophages.
Copyright (C) 2001 S. Karger AG. Basel.